Dr Gregory C. Gray joins Ethics Talk to discuss his article, coauthored with Drs Laura A. Pulscher and Hisham O. Alsharif: “Five Things Clinicians Need to Know About Zoonotic Viral Spillover and Spillback.”
John Timothy Kayiwa joins Ethics Talk to discuss his article, coauthored with Benard Matovu, Michael Mutebi, Charity Angella Nassuna, Leonara Nabatanzi, and Drs Kevin T. Castle, Robert M. Kityo, and Rebekah C. Kading: “How Should a One Health Perspective Promote Cross-Disciplinary Research About Bat-Associated Viruses in Uganda?”
When talking to physicians about practice variation, “Why does hospital A have higher cesarean rates than Hospital B?” is likely to be more effective than “Why does Doctor A have higher cesarean rates than Doctor B?”
Michael Farias, MD, MS, MBA and Rahul H. Rathod, MD
A distinguishing feature of a SCAMP is its ability to capture knowledge-based diversions from a recommended pathway and to “learn” from such individualized patient management.
Jack M. Berger, MS, MD, PhD and Nalini Vadivelu, MD
Guidelines for the use of controlled substances for the treatment of pain now consider inappropriate treatment, including undertreatment of pain, a departure from an acceptable standard of practice.
Developing drugs for profit is challenged in Parasites!, a patient education comic that highlights the need for unprofitable drugs for tropical diseases.
AMA J Ethics. 2018;20(2):167-175. doi:
10.1001/journalofethics.2018.20.2.msoc1-1802.